| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $698.8M | +29.7% |
| R&D Expense | $651.5M | +20.5% |
| SG&A Expense | $326.0M | +14.1% |
| Operating Income | -$447.4M | -19.5% |
| Pre-tax Income | -$587.5M | -13.3% |
| Income Tax | -$28.5M | -612.0% |
| Net Income | -$559.0M | -6.7% |
| EPS (Basic) | -$7.79 | -4.8% |
| EPS (Diluted) | -$7.79 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $279.8M | +47.5% |
| Short-term Investments | $130.9M | -77.6% |
| Accounts Receivable | $155.6M | +40.9% |
| Inventory | $21.8M | +37.5% |
| Current Assets | $693.8M | -27.3% |
| Total Assets | $1.71B | -12.0% |
| Current Liabilities | $406.2M | -20.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$356.7M | -41.9% |
| Capital Expenditures | $32.0M | +13.5% |
| Investing Cash Flow | $290.2M | +32.4% |
| Financing Cash Flow | $168.0M | +704.5% |
| Free Cash Flow | -$388.7M | -39.0% |
| -4.8% |
| Long-term Debt |
| $571.7M |
| +102.8% |
| Total Liabilities | $2.05B | +6.0% |
| Stockholders' Equity | -$347.1M | — |